Glycosphingolipide – Natur, Funktion und pharmakologische Modulierung
- 28 October 2009
- journal article
- aufsatz
- Published by Wiley in Angewandte Chemie
- Vol. 121 (47), 9006-9028
- https://doi.org/10.1002/ange.200902620
Abstract
No abstract availableKeywords
Funding Information
- NWO-CW
This publication has 242 references indexed in Scilit:
- Isofagomine Induced Stabilization of GlucocerebrosidaseChemBioChem, 2008
- The Spectrum of Parkinsonian Manifestations Associated With Glucocerebrosidase MutationsArchives of Neurology, 2008
- Crystal structure of the covalent intermediate of human cytosolic β-glucosidaseBiochemical and Biophysical Research Communications, 2008
- Chemical and Biological Approaches Synergize to Ameliorate Protein-Folding DiseasesCell, 2008
- The sphingolipid salvage pathway in ceramide metabolism and signalingCellular Signalling, 2007
- N4-Phenyl modifications of N2-(2-hydroxyl)ethyl-6-(pyrrolidin-1-yl)-1,3,5-triazine-2,4-diamines enhance glucocerebrosidase inhibition by small molecules with potential as chemical chaperones for Gaucher diseaseBioorganic & Medicinal Chemistry Letters, 2007
- CD1 mediated T cell recognition of glycolipidsCurrent Opinion in Structural Biology, 2007
- Selective action of the iminosugar isofagomine, a pharmacological chaperone for mutant forms of acid-β-glucosidaseBiochemical Pharmacology, 2007
- Sphingolipids—The Enigmatic Lipid Class: Biochemistry, Physiology, and PathophysiologyToxicology and Applied Pharmacology, 1997
- Intracellular transport and metabolism of sphingomyelinBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1991